hexamethylene bisacetamide has been researched along with bromodeoxyuridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PW; Fenderson, BA; Hakomori, S; Nudelman, E | 1 |
| de Gouw, M; de Laaf, R; Deschamps, J; Destrée, O; Meijlink, F; Verrijzer, P | 1 |
| Andrews, PW; Boncinelli, E; Mavilio, F; Simeone, A | 1 |
| Andrews, PW; Dignazio, M; Gönczöl, E; Oosterhuis, JW; Plotkin, SA | 1 |
| Barel, M; Charriaut, C; Frade, R | 1 |
5 other study(ies) available for hexamethylene bisacetamide and bromodeoxyuridine
| Article | Year |
|---|---|
Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
Topics: Acetamides; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Bromodeoxyuridine; Cell Membrane; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Glycolipids; Humans; Membrane Lipids; Retinoids; Teratoma; Tumor Cells, Cultured | 1990 |
The mouse Hox2.3 homeobox-containing gene: regulation in differentiating pluripotent stem cells and expression pattern in embryos.
Topics: Acetamides; Animals; Brain; Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Cloning, Molecular; DNA; DNA Restriction Enzymes; Embryo, Mammalian; Genes, Homeobox; Mice; Spinal Cord; Transcription, Genetic; Tretinoin | 1987 |
Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid.
Topics: Acetamides; Animals; Antigens, Surface; Bromodeoxyuridine; Cell Differentiation; Cell Line; Gene Expression Regulation; Genes, Homeobox; Humans; Mice; Stem Cells; Time Factors; Transcriptional Activation; Transplantation, Heterologous; Tretinoin; Tumor Cells, Cultured | 1988 |
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid.
Topics: Acetamides; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Cisplatin; Clone Cells; Cyclic AMP; Cytarabine; Dimethyl Sulfoxide; Humans; Idoxuridine; Kinetics; Neurons; Teratoma; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |
Use of cell differentiation effectors to select a human B lymphoblastoid cell line enriched in C3b receptors.
Topics: Acetamides; B-Lymphocytes; Bromodeoxyuridine; Bucladesine; Cell Line; Cell Separation; Cell Transformation, Neoplastic; Complement C3b; Diamines; Dimethyl Sulfoxide; Flow Cytometry; Humans; Receptors, Complement | 1981 |